Entelexo (YC W21)

Creating a new class of drugs to address incurable autoimmune diseases

https://wefunder.com/entelexo

Total raised on Wefunder: 32890

Total investors: 80

Quick facts

• >$1M raised to date, plus $310k on the same terms
• CEO led the 1st clinical trials in the world evaluating exosomes as a treatment for autoimmune disease
• Targeting 25M affected by immune-mediated diseases in US, equal to ~$150B in medical costs/year
• Our intellectual property is patent-protected (patent owned by the Company)
• Raising $2M for pre-clinical product development and IND enabling animal studies

Team profiles

• Milad Riazifar
• Todd Schurr
• Cameron Taylor

Featured investor profiles

• Nate Lipscomb